Southern Star Research
Sydney, Australia· Est.
Australia’s leading CRO for fast, cost‑effective early‑phase trials across APAC.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Australia’s leading CRO for fast, cost‑effective early‑phase trials across APAC.
CNSDermatologyOncologyMetabolicRare DiseasesVaccinesHealthy Volunteers
Technology Platform
Senior‑led, end‑to‑end early‑phase clinical trial execution platform that leverages Australia’s fast regulatory pathways, R&D tax incentives, and diverse patient populations to generate audit‑ready, globally accepted data.
Opportunities
Expanding APAC footprint and digital trial capabilities can capture growing demand for cost‑effective early‑phase studies and diversify sponsor pipelines.
Risk Factors
Regulatory changes in Australia or increased competition from other APAC CROs could erode cost‑advantage and market share.
Competitive Landscape
Competes with global CROs like ICON, Charles River, and PPD; differentiates through senior‑level engagement, rapid start‑up timelines, and lower cost structure.